无症状MRSA携带者去定植治疗期间及之后鼻腔与咽部微生物群变化
这项前瞻性观察研究纳入34名无症状鼻腔MRSA携带成人,接受5天2%莫匹罗星鼻膏联合4%氯己定皂清洁的去定植方案,用16S rRNA测序分析鼻腔和咽部微生物群。1个月随访时21/34(62%)去定植成功,鼻腔菌群在治疗2天内显著改变并持续30天,成功者3和6个月时鼻腔菌群仍与基线及116名未治疗对照不同,主要表现为Dolosigranulum和Moraxella持续耗竭。
要点
- 5天莫匹罗星联合氯己定去定植后1个月,62%(21/34)无症状鼻腔MRSA携带者去定植成功。
- 鼻腔菌群在治疗2天内显著改变,且成功者3和6个月时仍与基线及未治疗对照不同。
- 成功去定植者鼻腔Dolosigranulum和Moraxella持续耗竭,咽部菌群仅短期改变。
核心结论
- 去定植治疗显著改变鼻腔微生物群,既有短期效应也有持续效应。
- 成功去定植者鼻腔Dolosigranulum和Moraxella持续耗竭,未来可考虑治疗后补充有益鼻腔共生菌以促进微生态恢复。
研究设计与样本
- 前瞻性观察研究,纳入34名无症状鼻腔MRSA携带成人,接受5天2%莫匹罗星鼻膏联合每日4%氯己定皂皮肤清洁的去定植方案。
- 从基线至治疗后6个月多时间点采集鼻腔和咽部样本,行16S rRNA基因测序分析。
- 以116名未治疗的社区居住成人作为参照组进行比较。
主要发现
- 1个月随访时21/34(62%)成功去定植,13/34(38%)在一个或多个部位仍MRSA阳性。
- 基线时无鼻腔细菌分类群与鼻腔MRSA去定植结局显著相关。
- 鼻腔细菌群落在治疗头2天内显著改变,并在30天内持续不同于基线组成,成功去定植者与仍携带MRSA者均如此。
- 以S. aureus、凝固酶阴性葡萄球菌、Moraxella和Dolosigranulum为特征的鼻腔群落状态类型在治疗期间流行率下降,而以Corynebacterium和Cutibacterium为主的群落状态类型流行率上升。
- 成功去定植者治疗后3和6个月鼻腔微生物群仍与基线及参照组不同,主要因Dolosigranulum和Moraxella持续耗竭;咽部微生物群仅呈短期组成变化。
临床怎么用
- 对无症状鼻腔MRSA携带者行莫匹罗星联合氯己定去定植时,应意识到鼻腔微生态在治疗后数月至半年内仍偏离基线。
- 去定植成功者鼻腔Dolosigranulum和Moraxella持续耗竭,提示未来可探索治疗后补充有益共生菌以促进微生态恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Decolonization treatment of asymptomatic methicillin-resistant Staphylococcus aureus (MRSA) carriage is recommended as a preventive measure in several countries, including Denmark. This study aimed to investigate the temporal dynamics of the nasal and throat microbiota in MRSA carriers undergoing decolonization treatment and to assess bacterial changes associated with treatment success. METHODS: Adults with asymptomatic nasal MRSA carriage (n = 34) were included in this prospective observational study. Participants underwent a 5-day decolonization regimen consisting of 2% mupirocin nasal ointment and daily skin cleansing with 4% chlorhexidine soap. Nasal and throat samples were collected at multiple time points from baseline to 6 months after treatment and analysed by 16S rRNA gene sequencing. A reference group of untreated community-dwelling adults (n = 116) served as comparison. RESULTS: At 1-month follow-up, 21 of 34 participants (62%) were successfully decolonized, whereas 13 (38%) remained MRSA positive at one or more body sites. At baseline, no nasal bacterial taxa were significantly associated with nasal MRSA decolonization outcome. The nasal bacterial community changed significantly within the first 2 days of treatment and remained distinct from the baseline composition for 30 days, both among those with successful decolonization and those who remained colonized with MRSA. Nasal community state types characterized by S. aureus, coagulase-negative staphylococci, Moraxella, and Dolosigranulum became less prevalent during treatment, whereas community state types dominated by Corynebacterium and Cutibacterium increased in prevalence. Among successfully decolonized participants, the nasal microbiota at 3 and 6 months after treatment continued to differ from baseline and from the reference group, mainly because of a sustained depletion of Dolosigranulum and Moraxella. In contrast, the throat microbiota showed only short-term compositional changes. CONCLUSIONS: Decolonization treatment significantly alters the nasal microbiota, with both short-term and persistent effects. Future strategies could consider supplementation with beneficial nasal commensals, such as Dolosigranulum, after treatment to promote microbiome recovery.
引用
- Edslev SM, Liu CM, Sheng Lo BZ, et al. Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonization treatment in asymptomatic methicillin-resistant Staphylococcus aureus carriers: a longitudinal observational study. Clin Microbiol Infect. 2026. PMID: 41748020. doi:10.1016/j.cmi.2026.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。